micro-community-banner
  • Saved

5mo
Use of 2 Ventricular Assist Devices as a Total Artificial Heart for Heart Failure - PubMed

Use of 2 Ventricular Assist Devices as a Total Artificial Heart for Heart Failure - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/41055626/

HM6 implantation can be used to manage severe biventricular heart failure in patients who are not candidates for heart transplant.

A young patient with severe biventricular heart failure and ineligible for transplant underwent successful implantation of two HeartMate 3 devices (HeartMate 6 configuration) as a total artificial heart alternative.

  • Saved

5mo

Did you know? A Bulgarian study found 79 of 142 ADR reports on cardiovascular drugs were serious. Sartans like valsartan were linked to melanoma and other cancers within 2–5 years. Statins and ACE inhibitors also showed alarming reactions like MI, heart failure, and arrhythmia—calling for more vigilant prescribing and follow-up.

Could awareness of serious ADRs like cancer from sartans influence your approach to monitoring patients and selecting cardiovascular treatments?

NCCN Guidelines

Could awareness of serious ADRs like cancer from sartans influence your approach to monitoring patients and selecting cardiovascular treatments?

  • Saved

6mo
Background Image DesktopBackground Image Mobile

Genetic mutations were found in 71% of arrhythmia patients with cardiac devices. Variants in TMEM43 and titin (TTN) are linked to poor CRT outcomes. Personalised selection, such as using transvenous ICDs for ACM, improves prognosis and care.

Leverage genetics to tailor cardiac care

  • Saved

6mo
Worsening versus advanced heart failure: Management and challenges - PubMed

Worsening versus advanced heart failure: Management and challenges - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/41045229/

Heart failure (HF) is a progressive condition marked by recurrent episodes of symptom exacerbation, leading to worsening cardiac function, increased hospitalization and mortality risk. Worsening HF (WHF) and advanced HF...

 

This review differentiates worsening from advanced heart failure, emphasizing diagnostic criteria, clinical progression, and treatment strategies. It advocates early recognition to optimize therapy, prevent disease escalation, and improve outcomes in advanced stages.

 

  • Saved

6mo
Anti-ageing interventions for the treatment of cardiovascular disease - PubMed

Anti-ageing interventions for the treatment of cardiovascular disease - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/39172536/

As the global demographic landscape continues to shift towards an aged population, so does the medical and socioeconomic burden of cardiovascular diseases. Indeed, ageing is one of, if not, the...

Emerging anti-ageing strategies—epigenetic, metabolic, autophagy, senolytic, and anti-inflammatory therapies—may delay cardiovascular disease progression, reframing ageing as a modifiable risk factor.